Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity
about
Childhood obesityOsteoma cutis as the presenting feature of albright hereditary osteodystrophy associated with pseudopseudohypoparathyroidismDiagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossificationThe GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted geneIncreased prevalence of carpal tunnel syndrome in albright hereditary osteodystrophyGsα deficiency in the dorsomedial hypothalamus underlies obesity associated with Gsα mutations.Gsα Deficiency in the Ventromedial Hypothalamus Enhances Leptin Sensitivity and Improves Glucose Homeostasis in Mice on a High-Fat Diet.G(s)alpha deficiency in adipose tissue leads to a lean phenotype with divergent effects on cold tolerance and diet-induced thermogenesisAssociation of maternally inherited GNAS alleles with African-American male birth weightThe role of GNAS and other imprinted genes in the development of obesity.Bone mineral density in pseudohypoparathyroidism type 1a.Methylation defect in imprinted genes detected in patients with an Albright's hereditary osteodystrophy like phenotype and platelet Gs hypofunctionEating behaviors in obese children with pseudohypoparathyroidism type 1a: a cross-sectional study.A mouse model for osseous heteroplasiaPseudohypoparathyroidism: one gene, several syndromes.Evidence of hormone resistance in a pseudo-pseudohypoparathyroidism patient with a novel paternal mutation in GNAS.Effects of deficiency of the G protein Gsα on energy and glucose homeostasisProgressive osseous heteroplasia: diagnosis, treatment, and prognosisMadelung-like deformity in pseudohypoparathyroidism type 1bA positive genotype-phenotype correlation in a large cohort of patients with Pseudohypoparathyroidism Type Ia and Pseudo-pseudohypoparathyroidism and 33 newly identified mutations in the GNAS geneGNAS Spectrum of Disorders.Imprinting status of Galpha(s), NESP55, and XLalphas in cell cultures derived from human embryonic germ cells: GNAS imprinting in human embryonic germ cellsPediatric obesity: etiology and treatment.Increased Prevalence of Sleep Apnea in Children with Pseudohypoparathyroidism Type 1a.Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology.Gsα deficiency in the paraventricular nucleus of the hypothalamus partially contributes to obesity associated with Gsα mutationsResting Energy Expenditure Is Decreased in Pseudohypoparathyroidism Type 1A.Energy expenditure in obese children with pseudohypoparathyroidism type 1aPaternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLαs in fetal development.G(s)alpha deficiency in skeletal muscle leads to reduced muscle mass, fiber-type switching, and glucose intolerance without insulin resistance or deficiency.The GNAS Locus: Quintessential Complex Gene Encoding Gsalpha, XLalphas, and other Imprinted TranscriptsA Novel T55A Variant of Gs α Associated with Impaired cAMP Production, Bone Fragility, and Osteolysis.Central nervous system imprinting of the G protein G(s)alpha and its role in metabolic regulation.Physiological dysfunctions associated with mutations of the imprinted Gnas locus.Reduced insulin sensitivity in adults with pseudohypoparathyroidism type 1a.Parathyroid hormone signaling via Gαs is selectively inhibited by an NH(2)-terminally truncated Gαs: implications for pseudohypoparathyroidism.Postnatal establishment of allelic Gαs silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous Gαs disruptionPseudohypoparathyroidism Type 1A-Subclinical Hypothyroidism and Rapid Weight Gain as Early Clinical Signs: A Clinical Review of 10 Cases.Mice maintain predominantly maternal Gαs expression throughout life in brown fat tissue (BAT), but not other tissues.Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.
P2860
Q24620970-9C448F5D-4B2B-4C64-95EC-CB13B39579D8Q24631018-DC4D7FBD-F23E-44F4-8956-A64FBFF4F492Q24654579-977A87D9-E764-45E6-8529-69832E8732F0Q26852157-C0BE6C47-F798-4387-9BC0-C97B3AEFFA98Q28390224-4572600D-FA48-48D3-8730-E0B9C21FF60EQ30352984-3AF082DF-6D1C-4A09-9688-8733EA0D8BEBQ30354335-F6FD2DB7-68F2-40F6-BB6F-9BC423D1D609Q33824683-DD6491CB-881E-4BB1-86D0-7F66DE2A557EQ34083377-C2710756-F294-4C48-B2DE-925F153D7347Q34099397-42E631AC-6192-4817-B2CB-A08260F57373Q34113096-3202B141-D1C0-47CC-A57C-0BA6131300ADQ34297140-B64F6C2F-4877-4F23-8C9F-8DA78BACF112Q34379070-4CC1D7DC-7484-4669-9CE4-04AFF1487640Q34532358-901C4683-2170-421F-872D-11608CAFED78Q34547669-15E6727A-9ACB-4C77-BD72-EC44DE274FC8Q34751754-B092724E-CA26-41C5-96CD-3DEF1EB4C8FEQ34883776-94AF54DF-A12D-43B9-8196-6A9EE4DE7AF7Q35063732-8AB37261-43B8-42D3-94BC-FA5E89CD3512Q35198544-3D9FF65E-A371-4D00-A0F1-88677D75713EQ35198908-2258F59B-CBA5-4C6A-A2C2-3C32C004A21AQ35563016-644FE996-525D-4191-A8A0-A92C6D6F8DCAQ35613804-D7D10EEC-93C8-4BBA-BA98-CFC7719C20D8Q35678445-C4574729-840C-42CD-B279-8CCC09303615Q35967680-6A675909-4562-4918-8249-DD8C5621FE57Q36076341-0B0F821D-C672-4A8C-9C84-D1AF5B8259EFQ36177456-3B6BEEDC-574E-486C-94DF-62F4A1C6529AQ36716035-B01AA2FE-6932-430E-954A-62F876E9A44BQ36724381-3E119B2C-6EF6-4006-BD4B-CE5FDF17602BQ37149603-7916FA1B-ABE2-4E66-B756-9C6EFC8EE7F0Q37162369-20F3617F-1D89-40C4-B707-4BD60E6CF621Q37165427-08E6DCF3-A9A7-480E-A3A5-64D423E3A5BAQ37192455-B8D957FF-7F55-499D-8D19-B30572E71DDBQ37233680-7638F2C1-2EF6-49C2-BF60-446C9F7A64FFQ37242244-28BF8A27-E6C0-4384-BCC9-C2813A649F71Q37275997-DD70FAC6-2316-446C-98ED-B93848DA8A72Q37565140-2DE23A1F-9450-4639-BB7F-C6CB36746211Q37589286-081C3CB4-8E23-434D-A733-1937B0B32F4FQ38412094-0F5DE0C2-2A2C-493F-886E-343DFE66C373Q38685490-11C0DF36-2ADD-405F-A6E9-41A852D83BE6Q38816341-E48865D6-5067-48FF-937D-41DA7B1FF4E4
P2860
Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Body mass index differences in ...... e development of human obesity
@ast
Body mass index differences in ...... e development of human obesity
@en
Body mass index differences in ...... e development of human obesity
@nl
type
label
Body mass index differences in ...... e development of human obesity
@ast
Body mass index differences in ...... e development of human obesity
@en
Body mass index differences in ...... e development of human obesity
@nl
prefLabel
Body mass index differences in ...... e development of human obesity
@ast
Body mass index differences in ...... e development of human obesity
@en
Body mass index differences in ...... e development of human obesity
@nl
P2093
P3181
P356
P1476
Body mass index differences in ...... e development of human obesity
@en
P2093
Dominique N Long
Emily L Germain-Lee
Sarah McGuire
P304
P3181
P356
10.1210/JC.2006-1497
P407
P577
2007-03-01T00:00:00Z